New sequencer @BIOASTER

BIOASTER is pleased to announce the recent acquisition of the newest GridION, a sequencer of third generation entirely developed by Oxford Nanopore Technologies. This installation is the logical consequence of...

Certified Laboratory of biocrates for BIOASTER

Our OMIC team successfully completed Biocrates training and is now part of the certified laboratories able to handle this technology (Certified laboratories – biocrates life sciences ag). High quality metabolomic...

Mass spectrometer improvement: check it out!

BIOASTER is proud to share a successful installation of our new HPLC: Vanquish Neo (Thermofisher) coupled to our mass spectrometer Exploris 480 (Thermofisher). This system will allow us to increase...

Phage therapy at BIOASTER

#PhageTherapy at BIOASTER At @Bioaster, we have developed #preclinicalModels allowing To follow the concentration of #phages over time (#pharmacokinetics) in different fluids and organs after administration by various routes On...

BLOOD-ON-CHIP INITIATIVE

BIOASTER and Institut Pasteur are proud to join forces to build a novel microphysiological system (MPS) mimicking the first steps of immune activation during vaccination. This system will enable studying...

New APPLICATION NOTE available on Proteomics with COVARIS

New Application note available in collaboration with COVARIS entitled: A Robust and Standardized Workflow to Analyze C. albicans differential Protein Expression using Tandem Mass Tag (TMT) Abstract Yeast samples are...

BIOASTER publishes a new article in Frontiers in Immunology .

BIOASTER in collaboration with Cochin Hospital and the REALISM project consortium (study of the pathophysiology of intensive care patients and on biomarkers), has just published the article entitled “Assessing the...